Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.41 USD | +7.63% | +8.46% | +39.60% |
Mar. 04 | Passage Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 04 | Passage Bio, Inc. Appoints Kathleen Borthwick as Chief Financial Officer | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+39.60% | 80.71M | |
+9.15% | 105B | |
-1.08% | 104B | |
+5.79% | 22.94B | |
-11.55% | 22.34B | |
-7.01% | 19.25B | |
-37.08% | 17.08B | |
-9.91% | 16.96B | |
+7.55% | 14.16B | |
+40.04% | 12.63B |
- Stock Market
- Equities
- PASG Stock
- News Passage Bio, Inc.
- Wedbush Cuts Passage Bio's Price Target to $9 From $16, Citing PBKR03 Update, PBFT02 Timeline; Outperform Rating Kept